InnoBio Fund

InnoBio Fund

InnoBio Fund

Follow us
MedCity News

DBV Technologies' peanut allergy patch gets FDA review

£40,000,000 Venture capital (Series B)
PE HUB , FinSMEs

ENYO Pharma raises 40 mln pounds

Funding Health Science
€22,000,000 Venture capital (Series A)
FinSMEs

Enyo Pharma Secures €22M Series A Financing

Health Funding
$25,500,000 Venture capital (Series C)
VentureWire

DBV Technologies Raises $25.5M Series C For Peanut Allergy Patch

$281,500,000 Post-IPO equity
FinSMEs

DBV Technologies Closes $281.5M Public Offering

$2,700,000 Venture capital
VentureWire

DBV Raises Additional $2.7M To Develop Peanut Allergy Vaccine